M FACP - LMF Acquisition Chief Officer

All Insiders . USA . 
Stock . LMF Acquisition Opportunities . Stakeholders . Insider . M FACP
ICU Stock  USD 2.50  0.04  1.57%   

Insider

M FACP is Chief Officer of LMF Acquisition Opportunities
Age 51
Address 3513 Brighton Boulevard, Denver, CO, United States, 80216
Phone844 427 8100
Webhttps://www.seastarmedical.com

LMF Acquisition Management Efficiency

The company has Return on Asset of (3.0809) % which means that on every $100 spent on assets, it lost $3.0809. This is way below average. LMF Acquisition's management efficiency ratios could be used to measure how well LMF Acquisition manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -7.84 in 2024. Return On Capital Employed is likely to drop to 1.42 in 2024. Total Current Liabilities is likely to gain to about 13.7 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 3.2 M in 2024.
LMF Acquisition Opportunities has 9.08 M in debt. LMF Acquisition Oppo has a current ratio of 0.37, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for LMF to invest in growth at high rates of return.

Similar Executives

Showing other executives

INSIDER Age

James RolkeRevelation Biosciences
55
MD FAAAAIPalisade Bio
N/A
Annie RasmussenAllarity Therapeutics
67
Manuel DafonsecaSonnet Biotherapeutics Holdings
N/A
Denise CarterQuoin Pharmaceuticals Ltd
55
MBA MDImmix Biopharma
49
Nandan BSImmix Biopharma
62
Pablo MDZyVersa Therapeutics
N/A
Gabriel BAImmix Biopharma
37
Joan BrownAllarity Therapeutics
70
Sharon McBrayerPalisade Bio
N/A
Carol OdleRevelation Biosciences
N/A
Michael MyersQuoin Pharmaceuticals Ltd
62
Professor MDAllarity Therapeutics
67
DSc MSEImmix Biopharma
75
Cameron ShawVirax Biolabs Group
37
Jason DavisVirax Biolabs Group
52
JD MBAImmix Biopharma
N/A
Robert McRaePalisade Bio
N/A
Donald PickerCns Pharmaceuticals
78
Tomasz GeorgeVirax Biolabs Group
40
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT cardiorenal syndrome in congestive heart failure with and without LVAD myocardial stunning in end stage renal disease and hepatorenal syndrome. Seastar Medical operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3 people. LMF Acquisition Opportunities (ICU) is traded on NASDAQ Exchange in USA. It is located in 3513 Brighton Boulevard, Denver, CO, United States, 80216 and employs 12 people. LMF Acquisition is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Return On Asset-3.08

LMF Acquisition Oppo Leadership Team

Elected by the shareholders, the LMF Acquisition's board of directors comprises two types of representatives: LMF Acquisition inside directors who are chosen from within the company, and outside directors, selected externally and held independent of LMF. The board's role is to monitor LMF Acquisition's management team and ensure that shareholders' interests are well served. LMF Acquisition's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, LMF Acquisition's outside directors are responsible for providing unbiased perspectives on the board's policies.
Sai Iyer, Senior Research
M FACP, Chief Officer
Tim Varacek, Senior Operations
Eric Schlorff, President CEO
Tom Mullen, Vice Development
Caryl Baron, Interim Officer
David MD, CoFounder Director

LMF Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is LMF Acquisition a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset-3.08
Current Valuation13.12 M
Shares Outstanding4.46 M
Shares Owned By Insiders8.45 %
Shares Owned By Institutions4.93 %
Number Of Shares Shorted337.06 K
Price To Sales106.52 X
EBITDA(14.21 M)
Net Income(26.23 M)
Cash And Equivalents49 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for LMF Stock Analysis

When running LMF Acquisition's price analysis, check to measure LMF Acquisition's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LMF Acquisition is operating at the current time. Most of LMF Acquisition's value examination focuses on studying past and present price action to predict the probability of LMF Acquisition's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LMF Acquisition's price. Additionally, you may evaluate how the addition of LMF Acquisition to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY